153 related articles for article (PubMed ID: 12778064)
21. Familial risk for esophageal cancer: an updated epidemiologic study from Sweden.
Ji J; Hemminki K
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):840-5. PubMed ID: 16678496
[TBL] [Abstract][Full Text] [Related]
22. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K
JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687
[TBL] [Abstract][Full Text] [Related]
23. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
24. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.
Chuang GS; Lu LK; Cummins DL; Wu H; Finn D; Rogers GS; Lee D
Dermatol Surg; 2012 Sep; 38(9):1456-60. PubMed ID: 22734860
[TBL] [Abstract][Full Text] [Related]
25. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families.
Dong C; Hemminki K
Int J Cancer; 2001 Apr; 92(1):144-50. PubMed ID: 11279618
[TBL] [Abstract][Full Text] [Related]
26. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM; Hölmich LR; Smith S; Glud M; Andersen KK; Dalton SO; Drzewiecki KT
JAMA Dermatol; 2015 Oct; 151(10):1087-95. PubMed ID: 26061591
[TBL] [Abstract][Full Text] [Related]
27. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
28. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
29. Squamous Cell Carcinoma In Situ Upstaged to Invasive Squamous Cell Carcinoma: A 5-Year, Single Institution Retrospective Review.
Eimpunth S; Goldenberg A; Hamman MS; Oganesyan G; Lee RA; Hunnangkul S; Song SS; Greywal T; Jiang SIB
Dermatol Surg; 2017 May; 43(5):698-703. PubMed ID: 28060173
[TBL] [Abstract][Full Text] [Related]
30. Histologic Status of Squamous Cell Carcinoma In Situ After Diagnostic Biopsy in Immunocompetent and Immunosuppressed Patients.
Moioli EK; Hsieh C; Tisch A; Bolotin D
Dermatol Surg; 2018 Mar; 44(3):341-349. PubMed ID: 29053535
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
32. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway.
Hemminki K; Tretli S; Sundquist J; Johannesen TB; Granström C
Lancet Oncol; 2009 May; 10(5):481-8. PubMed ID: 19356978
[TBL] [Abstract][Full Text] [Related]
33. Incidence of invasive cancers following carcinoma in situ of the cervix.
Levi F; Randimbison L; La Vecchia C; Franceschi S
Br J Cancer; 1996 Oct; 74(8):1321-3. PubMed ID: 8883426
[TBL] [Abstract][Full Text] [Related]
34. The systematic relationship between melanomas diagnosed in situ and when invasive.
Lee JA
Melanoma Res; 2001 Oct; 11(5):523-9. PubMed ID: 11595891
[TBL] [Abstract][Full Text] [Related]
35. The nation-wide Swedish family-cancer database--updated structure and familial rates.
Hemminki K; Li X; Plna K; Granström C; Vaittinen P
Acta Oncol; 2001; 40(6):772-7. PubMed ID: 11765074
[TBL] [Abstract][Full Text] [Related]
36. Familial and second lung cancers: a nation-wide epidemiologic study from Sweden.
Li X; Hemminki K
Lung Cancer; 2003 Mar; 39(3):255-63. PubMed ID: 12609563
[TBL] [Abstract][Full Text] [Related]
37. Familial cancer risks in offspring from discordant parental cancers.
Vaittinen P; Hemminki K
Int J Cancer; 1999 Mar; 81(1):12-9. PubMed ID: 10077145
[TBL] [Abstract][Full Text] [Related]
38. Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer.
Brandt A; Sundquist J; Hemminki K
Br J Dermatol; 2011 Aug; 165(2):342-8. PubMed ID: 21457213
[TBL] [Abstract][Full Text] [Related]
39. Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms?
Chattopadhyay S; Hemminki A; Försti A; Sundquist K; Sundquist J; Hemminki K
J Invest Dermatol; 2020 Jan; 140(1):48-55.e1. PubMed ID: 31288011
[TBL] [Abstract][Full Text] [Related]
40. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden.
Hemminki K; Li X
Int J Cancer; 2003 Feb; 103(4):525-30. PubMed ID: 12478670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
